Bausch + Lomb

Bausch + Lomb

Yahoo Finance • 3 days ago

3 Low-Volatility Stocks with Open Questions

3 Low-Volatility Stocks with Open Questions A stock with low volatility can be reassuring, but it doesn't always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.... Full story

Yahoo Finance • 5 days ago

Bausch + Lomb makes progress on development of oral treatment for dry AMD

[Macular Degeneration] George Robinson/iStock via Getty Images * Bausch + Lomb said that it has made progress in its development of tonabersat (BL1243), an oral treatment for dry age-related macular degeneration, following a meeting wit... Full story

Yahoo Finance • last month

Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers

Bausch + Lomb stock has delivered a 17.2% return over the past year, yet several valuation checks still flag the shares as cheap relative to an intrinsic value estimate and to market multiples. For investors, the puzzle is why a stock with... Full story

Yahoo Finance • last month

3 Healthcare Stocks We Steer Clear Of

3 Healthcare Stocks We Steer Clear Of From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare st... Full story

Yahoo Finance • 2 months ago

Bausch + Lomb Advances Two First-in-Class Eye Health Therapies

Bausch + Lomb BLCO recently announced that two first-in-class pharmaceutical pipeline candidates will advance to the next stages of clinical development following positive trial results. The programs include a dual-action eye drop for dry... Full story

Yahoo Finance • 2 months ago

These stocks have some of Wall Street’s lowest short interest

[short sale] abluecup Stocks including Apple, Alphabet, Exxon Mobil, and JPMorgan are among the companies with relatively low short interest, according to a screen of stocks with market capitalizations above $2B. The screen includes stoc... Full story

Yahoo Finance • 2 months ago

Most and least shorted mid- to mega-cap healthcare stocks at the end of July

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Short interest data from late July 2026 highlights deeply divided investor sentiment across the healthcare sector. S... Full story

Yahoo Finance • 3 months ago

3 Reasons to Avoid BLCO and 1 Stock to Buy Instead

3 Reasons to Avoid BLCO and 1 Stock to Buy Instead Over the past six months, Bausch + Lomb's stock price fell to $15.99. Shareholders have lost 7% of their capital, which is disappointing considering the S&P 500 has climbed by 7.7%. This... Full story

Yahoo Finance • 3 months ago

3 Small-Cap Stocks We Steer Clear Of

3 Small-Cap Stocks We Steer Clear Of Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside ris... Full story

Yahoo Finance • 5 months ago

Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting

VAUGHAN, Ontario, April 30, 2026--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it will deliver more than 40 sci... Full story

Yahoo Finance • 5 months ago

Bausch Health Q1 Adjusted Earnings, Revenue, Advance, Beating Estimates

Bausch Health (BHC.TO) up 3.6% in after-hours New York trade, after the company on Wednesday said it PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 6 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index adding 1.6% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 6 months ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index and the State Street He PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 6 months ago

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and over the past six months, the industry has held its g... Full story

Yahoo Finance • 6 months ago

Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe

enVista Envy is the first diffractive premium IOL from Bausch + Lomb available in Europe Offers a continuous range of vision with excellent dysphotopsia tolerance EyeGility™ delivery system contributes to smooth, efficient lens delivery V... Full story

Yahoo Finance • 7 months ago

3 Reasons BLCO is Risky and 1 Stock to Buy Instead

Even during a down period for the markets, Bausch + Lomb has gone against the grain, climbing to $16.01. Its shares have yielded a 10.4% return over the last six months, beating the S&P 500 by 11.7%. This run-up might have investors contem... Full story

Yahoo Finance • 7 months ago

A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story

Key Points Alfonso Eduardo acquired 4,300 common shares on March 2, 2026, at around $17.90 per share, for a total transaction value of ~$77,000. Bausch + Lomb, matched his purchase with restricted stock units, raising his direct holdings... Full story

Yahoo Finance • 7 months ago

Bausch + Lomb Higher in New York Trading, Reports Positive Elios Trial Results

Bausch + Lomb (BLCO.TO), up 5% in New York trading, Monday announced positive 24-month results from PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 7 months ago

2 Profitable Stocks Worth Investigating and 1 We Ignore

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. Not all profitable companies are created equal,... Full story

Yahoo Finance • 7 months ago

FedEx, EssilorLuxottica sued by customers for tariff refunds

[US Tariffs Legal Challenges] Shipping giant FedEx (FDX [https://seekingalpha.com/symbol/FDX]) and French eyewear firm EssilorLuxottica (ESLOY [https://seekingalpha.com/symbol/ESLOY]) are facing lawsuits from customers seeking a portion o... Full story